Manualized therapy + MIDOMAFETAMINE for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Sep 2017: Trial registered, NCT03282123
  2. 16 Nov 2017: Trial started, NCT03282123

The trials

NCT03282123: Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

State
Completed
Phase
Phase 2
People
38 taking part
Started
16 Nov 2017
Primary completion
10 Aug 2019
Arms
MDMA-assisted therapy
Results
Posted on the registry
  1. 13 Sep 2017: Trial registered
  2. 16 Nov 2017: Trial started
  3. 10 Aug 2019: Trial completed
  4. 29 Jul 2021: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.